NeuBase Therapeutics Inc (NBSE): (NASDAQ: NBSE) shares surged 14.5% to $0...

Send PM Follow Ignore

Followers	81
Posts	6372
Boards Moderated	4
Alias Born	01/14/2015

81vette

Re: None

Monday, 02/26/2024 10:30:35 AM

Monday, February 26, 2024 10:30:35 AM

(NASDAQ: NBSE) shares surged 14.5% to $0.86 in pre-market trading. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NBSE News

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq • GlobeNewswire Inc. • 04/05/2024 08:05:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:01:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:01:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 01:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:15:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 12:00:12 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/28/2023 11:15:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 11:15:44 AM
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance • GlobeNewswire Inc. • 11/27/2023 02:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:11:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 11:30:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 12:00:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:36 PM
Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2023 12:42:52 AM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/20/2023 09:28:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 08:32:12 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/18/2023 08:20:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:17:52 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/14/2023 10:03:41 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2023 09:08:11 PM
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder • GlobeNewswire Inc. • 09/08/2023 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 09:19:32 PM

More NBSE News

InvestorsHub NewsWire

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover